LGALS3 and metabolic syndrome: MetS was previously linked to high plasma galectin-3 levels, and the combination of MetS with galectin-3 above the 75th percentile significantly increases heart failure risks more than four-fold (over a four-fold higher long-term risk to develop heart failure) [86].